Recently, a randomized double-blind, placebo-controlled trial indicated that butyrate and insulin supplementation significantly reduced fasting blood glucose and waist to hip ratio in T2DM patients (Roshanravan et al., 2017). This evidence concerns the gene INS and type 2 diabetes mellitus.